-
Entertainment
Taylor Swift Turns Showgirl With Dazzling Album Drop and Kelce Confession
Taylor Swift’s The Life of a Showgirl is here complete with fries, midnight Target drops, and a love story written…
Read More » -
Politics
No Evidence Found of ‘Mixcoa Protest’ in U.S. on October 3
Online chatter hyped a supposed “Mixcoa Protest” on October 3, but no such event occurred. Instead, the real protest wave…
Read More » -
Sports
Cristian Roldan Named to USMNT October Roster Amid World Cup Push
Cristian Roldan is back with the U.S. men’s national team as Mauricio Pochettino prepares his squad for October friendlies against…
Read More » -
Politics
Terror Attack on Manchester Synagogue Leaves Two Dead on Yom Kippur
A deadly attack outside a Manchester synagogue on Yom Kippur left two dead and several wounded. Police shot the suspect,…
Read More » -
Politics
Trump Turns Shutdown Into Stage for Project 2025 Shake-Up
President Trump is treating the shutdown as a reboot moment using Project 2025 to slash agencies, centralize power, and freeze…
Read More » -
Entertainment
Danica Patrick Slams NFL Over Bad Bunny Super Bowl Halftime Show
Danica Patrick sparked outrage with her take on Bad Bunny’s Super Bowl halftime show, insisting the NFL shouldn’t allow Spanish-only…
Read More » -
Entertainment
Kelly Ripa Turns 55 With On-Air Banter, Viral Mic Slip, and Red-Carpet Glam
Kelly Ripa’s 55th birthday week delivered the perfect mix of comedy, glamour, and emotion from a mic slip that went…
Read More » -
Entertainment
Nicki Minaj vs Cardi B: Boycotts, Album Sales, and a Feud Gone Nuclear
Nicki Minaj and Cardi B are back at it, sparring over album sales, calling out brand deals, and dragging family…
Read More » -
Entertainment
Jacob Elordi Unveils Monster Transformation in Guillermo del Toro’s Frankenstein
Jacob Elordi’s monster face is finally revealed in Guillermo del Toro’s Frankenstein trailer. Off-screen, the actor opens up about fatherhood…
Read More » -
Business
Eli Lilly’s LLY Stock Surges on Drug Tariff Boost and Trial Shifts
LLY stock rallies as Eli Lilly benefits from U.S. tariff protections, a favorable drug pricing outlook, and pipeline trial adjustments.
Read More »
Advertisement
